Bud Hill has a 30 year track record in developing companies in the Medical Device marketplace. Mr. Hill’s background includes developing organization and products for use in Heart Valve Components, Brain Shunts, Inner Ear Tubes, Knee Replacement Parts and Dental Implants. One of his recent companies, Core-Vent, manufactured products for distribution by Johnson and Johnson, Baxter Corporation and SBM. Core-Vent was sold for a price of over $300 million. Mr. Hill currently and actively advises companies in the areas of: (i) Design of Medical Devices (knee and hip replacements, bone screws, breast implants). (ii) Manufacturing Principles: includes taking the design of various Medical Devices through the Patent Process. (iii) Patent Processes. (iv) 510k and FDA certification.
Jeff Glattstein is a seasoned executive recognized for his accomplishments at creating, developing and strengthening companies by implementing strong Corporate Development, Business Development, Marketing, Operational Strategies and Corporate Financing plans. As a CEO of two companies, Mr. Glattstein led the development, establishment and growth of both companies; from start up to exit strategy. Mr. Glattstein was responsible for over $50 million of capital raised and the development of over $200 million in revenue.
Patrick Doran is a senior-level executive offering over 20 years of diversified experience creating and executing strategies to yield significant financial results for blue chip companies such as MTV Networks, Turner Broadcasting Systems, Inc., and MGM/UA. Career accomplishments include: developing and implementing a comprehensive advertising sales strategy to expand customer base and generate 200% annual revenue growth in two years. Mr. Doran’s core competencies include: Strategic Planning, Operational Management, Budget & Cash Flow Management, Sales & Product Distribution and P&L Management.
Glenn Charlesworth is a senior-level executive with over 25 years of experience in Finance and Operations for private and publicly traded companies. Career accomplishments include: senior leadership as the first CFO of a new publicly traded medical device company, leadership to the financial team of a dynamic, growth oriented multi-media, and multi-entity, organization with the focus of managing the accounting and finance team during a period of extreme growth and multiple sales and purchases of business entities, and subsequently a merger with a public company. Mr. Charlesworth’s core competencies include: financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations. Experienced in recruiting, motivating, developing, and retaining talent within a values-oriented team framework.
Jonathan Satin has been a leader in the performance textile industry since 1992. Mr. Satin has a decade long track record of spotting market trends and developing organizations to bring those ideas to market.
Dave McLachlan is the Vice President of Development. Mr. McLachlan possesses more then 15 years in the advertising and marketing industry. Most recently, Mr. McLachlan worked as a Director of Sourcing for Capital Partners – he raised over $30 Million in new projects. Mr. McLachlan’s proven leadership abilities and managerial skills will ensure the prosperity of the Company.
Ronnie Hoffman has over 20 years of experience in sourcing of medical textiles. Mr. Hoffman is well versed in negotiating prices, securing manufacturing facilities and landing finished garments from overseas.
Richard Knecht is an attorney specializing in corporate, securities and regulatory law. Mr. Knecht has over 30 years of experience in the private equity and public banking industries. Mr. Knecht currently serves the Board of Directors of over a dozen financial institutions.
STATEN ISLAND, N.Y. — Legislation that would forbid doctors and other hospital workers from wearing neckties in clinical settings, to reduce the transmission of germs, is being pushed by state Sen. Diane Savino and other members of the breakaway Democratic conference. But Staten Island physicians oppose the move, saying there’s no hard evidence to show [...]